Gartner (IT) Q2 2026 earnings review
Profits Surge on Buybacks and Cost Control, While Top-Line Growth Lags
Gartner delivered a massive bottom-line beat in Q2 2026, with Adjusted EPS surging 23.8% to $4.37 despite a reported revenue decline of 0.6% (Adjusted Revenue grew 2.8% excluding divestitures). The company's aggressive financial engineering—highlighted by $547 million in share repurchases and a fresh $500 million authorization—continues to mask sluggish organic demand. While management cheered that Contract Value (CV) growth 'accelerated again,' total FX-neutral CV growth was a meager 1.7% YoY. Gartner is heavily reliant on buybacks and margin expansion to hit its long-term targets while it waits for a turbulent macroeconomic environment to normalize.
🐂 Bull Case
Adjusted EBITDA (excluding divested operations) grew 6.4%, vastly outpacing revenue growth. Operational leverage and internal productivity gains are driving highly efficient earnings generation.
The company repurchased 3.6 million shares for $547 million in the quarter alone. With a new $500 million authorization added to existing reserves, buybacks provide a hard floor for EPS growth.
🐻 Bear Case
Despite management calling it an 'acceleration,' total FX-neutral Contract Value grew just 1.7%. Historically, Gartner targeted double-digit CV growth, making current performance look deeply recessionary.
Consulting revenues fell 8.8% YoY to $142 million, indicating severe client hesitancy on discretionary project spending amidst geopolitical and macroeconomic uncertainties.
⚖️ Verdict: ⚪
Neutral. The bottom-line execution and cash generation are spectacular, but you are buying a growth stock that is struggling to generate meaningful top-line organic growth. The reliance on buybacks to manufacture EPS growth is an effective but finite strategy.
Key Themes
Contract Value is Accelerating, But Remains Severely Depressed
Management noted that Contract Value (CV) growth 'accelerated again.' While technically true—Total FX-neutral CV growth ticked up from 1.0% in recent quarters to 1.7% in Q2—the absolute numbers remain shockingly low for a company that historically targets double-digit growth. Global Technology Sales (GTS) CV, the company's largest segment, crawled to just 1.1% YoY growth. This stubbornly slow recovery contradicts the highly optimistic narrative management has been pushing regarding imminent re-acceleration.
Financial Engineering is the Primary Growth Driver
With organic growth constrained, share repurchases are doing the heavy lifting. Gartner bought back 3.6 million shares for $547 million in Q2 (approximately 5% of its market cap annualized). The Board added another $500 million to the authorization in July. This aggressive capital return strategy is the primary driver allowing the company to report 23.8% Adjusted EPS growth despite almost flat revenue, and is the cornerstone of their promise to deliver a >12% EPS CAGR over the next three years.
Consulting Segment is Breaking Trend
The Consulting segment was a glaring weak spot, reversing trend with an 8.8% YoY revenue decline (to $142 million) and a 12.6% drop in gross contribution. While the subscription-based Insights segment is stable, the Consulting drop strongly suggests that enterprises are tightening their belts on discretionary, project-based spending due to macro uncertainty.
Conferences Segment Showing Extreme Resilience
In stark contrast to Consulting, the Conferences segment is accelerating. Revenues jumped 15.5% YoY to $244 million, with gross contribution surging 19.6%. This indicates that while clients are delaying long-term consulting engagements, they still place massive value on in-person networking and immediate tactical insights gained at Gartner's destination events.
Internal AI and 'Ask Gartner' UX Driving Margins
While top-line AI monetization remains indirect, Gartner's internal use of AI to drive productivity is bearing fruit. The company previously cited a 75% reduction in publishing time using proprietary neural networks. This operational leverage is clearly visible in Q2: Adjusted EBITDA margins (excluding divested operations) expanded robustly, allowing EBITDA to grow 6.4% on 2.8% adjusted revenue growth.
Lingering Geopolitical and Macroeconomic Headwinds
Management's forward-looking statements in the PR explicitly cited risks surrounding 'tensions in the Middle East, the war in Ukraine' and shifting trade policies/tariffs. In prior quarters, management admitted these macro factors caused sudden freezes in client decision-making (e.g., the 'March slowdown'). Given the anemic 1.1% growth in GTS Contract Value, it appears these elongated sales cycles and C-suite deal escalations are persisting.
Other KPIs
Accelerating. FCF grew 8.9% YoY, driven by higher operating income and disciplined capital expenditures (which fell to $20M from $36M a year ago). This cash generation perfectly funds the company's aggressive buyback program without requiring excessive leverage.
Stable and highly profitable. Up 6.4% as reported (+4.4% FX neutral). The ability to grow earnings at roughly 3x the pace of revenue demonstrates excellent cost controls following 2025's restructuring efforts.
Guidance
Accelerating. Management officially raised the full-year Adjusted EPS guidance from the prior baseline of 'at or above $13.25'. This confirms the buyback program and margin expansion are operating ahead of schedule.
Accelerating. Increased from the previous Q1 floor of $1.545 billion, proving that internal AI efficiencies and cost discipline are generating permanent structural margin improvements.
Accelerating. Raised from the prior floor of $1.16 billion. Essential for funding the newly increased $500M buyback authorization.
Key Questions
Contract Value Discrepancy
You noted that Contract Value 'accelerated again,' yet GTS CV growth is only 1.1% YoY. Can you break down how much of this slight acceleration is simply lapping the U.S. Federal Government cancellations versus genuine organic demand recovery?
Consulting Segment Deterioration
Consulting revenue fell nearly 9% this quarter. Are you seeing clients cancel projects outright, or are these merely deferrals? How does this impact your Contract Optimization business?
Limits of Financial Engineering
With 23.8% Adjusted EPS growth generated largely by share count reduction and cost controls on flat revenue, how long can this model sustain your >12% EPS CAGR target before top-line re-acceleration becomes a mathematical necessity?